Skip to main content
. 2021 Jan 13;13(2):273. doi: 10.3390/cancers13020273

Figure 5.

Figure 5

Kaplan Meier survival curves for the correlation between dyskerin immunoscores and patient outcome. (A) Disease-free survival (DFS), the median DFS time is undefined for low dyskerin and high dyskerin endometrial cancer groups. Hazard ratio (HR) = 1.92, 95% CI of the ratio (0.9200–4.006) (B) Cancer-specific survival (CSS), the median CSS time was undefined for low dyskerin and high dyskerin endometrial cancer groups. HR = 1.991, 95% CI of HR (0.9300–4.261) and (C) Overall survival (OS) in endometrial cancer samples (n = 109). Median OS time: Low dyskerin protein 8.00 months, High dyskerin protein 2.00 months. Low dyskerin/high dyskerin median survival Ratio: 0.5217, 95% CI of ratio (0.004444–1.039) HR = 1.841, 95% CI of HR (0.9667–3.506). A quickscore of 6 was chosen as the cut-off point. The p values relevant to the difference between low and high dyskerin protein levels in endometrial cancer groups that is visually represented in Kaplan Meier survival curves from the log-rank test.